HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

rufinamide

structure in first source
Also Known As:
1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide; CGP 33101; CGP-33101; 1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)-
Networked: 90 relevant articles (31 outcomes, 34 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Coppola, Giangennaro: 8 articles (07/2015 - 11/2010)
2. Verrotti, Alberto: 7 articles (07/2015 - 11/2010)
3. Kluger, Gerhard: 7 articles (11/2014 - 02/2007)
4. Curatolo, Paolo: 6 articles (11/2014 - 11/2010)
5. Kluger, G: 6 articles (09/2012 - 05/2008)
6. Narurkar, Milind: 5 articles (05/2011 - 12/2009)
7. Parisi, Pasquale: 4 articles (09/2014 - 11/2010)
8. Mann, Allison: 4 articles (02/2011 - 08/2009)
9. Moavero, Romina: 3 articles (11/2014 - 11/2012)
10. Cusmai, Raffaella: 3 articles (11/2014 - 11/2012)

Related Diseases

1. Seizures (Seizure)
2. Epilepsy (Aura)
3. Syncope (Fainting)
4. Partial Epilepsies (Epilepsy, Partial)
5. Spasm (Spasms)

Related Drugs and Biologics

1. Lennox-Gastaut type Epileptic encephalopathy
2. felbamate (Felbatol)
3. lamotrigine (Lamictal)
4. topiramate (Topamax)
5. clobazam (HR 376)
6. Anticonvulsants (Antiepileptic Drugs)
7. lacosamide
8. perampanel
9. BIA 2-093
10. Sirolimus (Rapamycin)

Related Therapies and Procedures

1. Stents
2. Electric Stimulation Therapy (Electrotherapy)
3. Off-Label Use